Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Tolnaftate+chlorhexidine hydrochloride |
Has active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Nystatin+chlorhexidine hydrochloride |
Has active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride and neomycin sulfate adverse reaction |
Causative agent |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Allergy to chlorhexidine hydrochloride and neomycin sulfate |
Causative agent |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Product containing chlorhexidine and tolnaftate (medicinal product) |
Has active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has precise active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has basis of strength substance (attribute) |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has precise active ingredient |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has basis of strength substance (attribute) |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has precise active ingredient |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Allergy to chlorhexidine hydrochloride and neomycin sulfate |
Causative agent |
False |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has precise active ingredient |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has basis of strength substance (attribute) |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) |
Has precise active ingredient |
True |
Chlorhexidine hydrochloride |
Inferred relationship |
Some |
2 |